A Real‐Word Analysis of the Correlation Between Clinical Efficacy and Predictive Factors of Immune‐Related Adverse Events in Patients With Nonsmall Lung Cancer Treated With Nivolumab Plus Ipilimumab
Patients who experienced AEs had significantly longer PFS. Among AEs, the occurrence of skin disorders, adrenal insufficiency, and eosinophilia were likely to prolong PFS and OS.
Authors
- Hiroshi Kagamu (ORCID: https://orcid.org/0000-0003-4523-8517)
- Ayako Shiono (ORCID: https://orcid.org/0000-0001-6546-3864)
- Kasumi Tsukamoto
- Yuhei Kurata
- Kunihiko Kobayashi (ORCID: https://orcid.org/0000-0002-6468-9068)
- Kyoichi Kaira (ORCID: https://orcid.org/0000-0001-5548-7686)
- Hisao Imai (ORCID: https://orcid.org/0000-0003-3097-4255)
- Kosuke Hashimoto (ORCID: https://orcid.org/0000-0003-3031-0635)
- Ou Yamaguchi (ORCID: https://orcid.org/0000-0001-7194-6459)
- Kenji Masaki
- Junichi Nakagawa (ORCID: https://orcid.org/0000-0003-2340-2267)
- Satoshi Endo (ORCID: https://orcid.org/0000-0002-8477-5553)
- Atsuto Mouri (ORCID: https://orcid.org/0000-0001-8704-8151)
- Yu Miura (ORCID: https://orcid.org/0000-0002-2752-5873)
Institutions
- National Hospital Organization Takasaki Medical Center (JP)
- National Hospital Organization (JP)
- National Disaster Medical Center (JP)
- Hyogo Prefectural Cancer Center (JP)
- National Defense Medical College (JP)
- Saitama Medical University (JP)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2025-04-01
- DOI
- https://doi.org/10.1002/cam4.70741
- Citations
- 1
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 1.05